These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 17368178)
41. Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription. MacDonald PN; Baudino TA; Tokumaru H; Dowd DR; Zhang C Steroids; 2001; 66(3-5):171-6. PubMed ID: 11179724 [TBL] [Abstract][Full Text] [Related]
42. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. Imai Y; Pike JW; Koeffler HP Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077 [TBL] [Abstract][Full Text] [Related]
43. Molecular mechanism of the vitamin D antagonistic actions of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone depends on the primary structure of the carboxyl-terminal region of the vitamin d receptor. Ochiai E; Miura D; Eguchi H; Ohara S; Takenouchi K; Azuma Y; Kamimura T; Norman AW; Ishizuka S Mol Endocrinol; 2005 May; 19(5):1147-57. PubMed ID: 15650022 [TBL] [Abstract][Full Text] [Related]
44. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation. Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583 [TBL] [Abstract][Full Text] [Related]
45. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions. Herdick M; Steinmeyer A; Carlberg C Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341 [TBL] [Abstract][Full Text] [Related]
47. Previtamin D3 with a trans-fused decalin CD-ring has pronounced genomic activity. Verlinden L; Verstuyf A; Verboven C; Eelen G; De Ranter C; Gao LJ; Chen YJ; Murad I; Choi M; Yamamoto K; Yamada S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R J Biol Chem; 2003 Sep; 278(37):35476-82. PubMed ID: 12829710 [TBL] [Abstract][Full Text] [Related]
48. Ligand-dependent conformation change reflects steric structure and interactions of a vitamin D receptor/ligand complex: a fragment molecular orbital study. Motoyoshi S; Yamagishi K; Yamada S; Tokiwa H J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):56-9. PubMed ID: 20236615 [TBL] [Abstract][Full Text] [Related]
49. Enhancement of ligand-dependent vitamin D receptor transactivation by the cardiotonic steroid bufalin. Nakano H; Matsunawa M; Yasui A; Adachi R; Kawana K; Shimomura I; Makishima M Biochem Pharmacol; 2005 Nov; 70(10):1479-86. PubMed ID: 16183038 [TBL] [Abstract][Full Text] [Related]
50. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets. Malloy PJ; Zhu W; Zhao XY; Pehling GB; Feldman D Mol Genet Metab; 2001 Jun; 73(2):138-48. PubMed ID: 11386849 [TBL] [Abstract][Full Text] [Related]
51. The critical role of carboxy-terminal amino acids in ligand-dependent and -independent transactivation of the constitutive androstane receptor. Andersin T; Väisänen S; Carlberg C Mol Endocrinol; 2003 Feb; 17(2):234-46. PubMed ID: 12554751 [TBL] [Abstract][Full Text] [Related]
52. Transcriptional activation of the wild-type and mutant vitamin D receptors by vitamin D3 analogs. Futawaka K; Tagami T; Fukuda Y; Koyama R; Nushida A; Nezu S; Yamamoto H; Imamoto M; Kasahara M; Moriyama K J Mol Endocrinol; 2016 Jul; 57(1):23-32. PubMed ID: 27154546 [TBL] [Abstract][Full Text] [Related]
53. Phosphorylation at serine 208 of the 1alpha,25-dihydroxy Vitamin D3 receptor modulates the interaction with transcriptional coactivators. Arriagada G; Paredes R; Olate J; van Wijnen A; Lian JB; Stein GS; Stein JL; Onate S; Montecino M J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):425-9. PubMed ID: 17368182 [TBL] [Abstract][Full Text] [Related]
54. Antagonistic action of a 25-carboxylic ester analogue of 1alpha, 25-dihydroxyvitamin D3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators. Herdick M; Steinmeyer A; Carlberg C J Biol Chem; 2000 Jun; 275(22):16506-12. PubMed ID: 10748178 [TBL] [Abstract][Full Text] [Related]
55. Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix H10 residues. Barry JB; Leong GM; Church WB; Issa LL; Eisman JA; Gardiner EM J Biol Chem; 2003 Mar; 278(10):8224-8. PubMed ID: 12529369 [TBL] [Abstract][Full Text] [Related]
56. The role of the vitamin D receptor and ERp57 in photoprotection by 1α,25-dihydroxyvitamin D3. Sequeira VB; Rybchyn MS; Tongkao-On W; Gordon-Thomson C; Malloy PJ; Nemere I; Norman AW; Reeve VE; Halliday GM; Feldman D; Mason RS Mol Endocrinol; 2012 Apr; 26(4):574-82. PubMed ID: 22322599 [TBL] [Abstract][Full Text] [Related]
57. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity. Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040 [TBL] [Abstract][Full Text] [Related]
58. New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model. Mizwicki MT; Bula CM; Bishop JE; Norman AW J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):243-62. PubMed ID: 17368177 [TBL] [Abstract][Full Text] [Related]
59. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements. Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990 [TBL] [Abstract][Full Text] [Related]
60. Crystal Structure of the Vitamin D Receptor Ligand-Binding Domain with Lithocholic Acids. Ikura T; Ito N Vitam Horm; 2016; 100():117-36. PubMed ID: 26827950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]